2014
DOI: 10.1016/j.ejmg.2014.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Implementation of genomic arrays in prenatal diagnosis: The Belgian approach to meet the challenges

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
114
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 90 publications
(115 citation statements)
references
References 27 publications
1
114
0
Order By: Relevance
“…The deletion contained not only the EVC and EVC2 genes, but also STK32B and C4orf6, as in our case . It is important to underline that the deletion present Belgium, all genetic centres participate in a consortium to deal with this issue 13 .…”
Section: Letter To Editormentioning
confidence: 99%
“…The deletion contained not only the EVC and EVC2 genes, but also STK32B and C4orf6, as in our case . It is important to underline that the deletion present Belgium, all genetic centres participate in a consortium to deal with this issue 13 .…”
Section: Letter To Editormentioning
confidence: 99%
“…Clinically relevant genomic imbalances are reported in 4%-7% of fetuses with ultrasound detected structural anomalies (7,9,10). Some laboratories completely switched over their prenatal invasive diagnosis to aCGH (11). Apart from the fact that aCGH is more expensive compared to conventional karyotyping, there is another very important issue in prenatal diagnosis, i.e.…”
Section: Genomic Tests In Prenatal Genetic Diagnosismentioning
confidence: 99%
“…However, that may be changing. Even though prenatal genetic testing is usually subjected to more restrictions than postnatal testing, the directors of Belgian diagnostic laboratories recently reached a consensus that, when performing prenatal microarrays, they would report structural variants that affected genes for adult-onset disorders on the 56 gene ACMG list (31). Informal support for the reporting of adult results in children extends to clinical WES/WGS; a recent survey of geneticists found that the large majority would report medically actionable IFs for adult disease in children tested by clinical WGS (32).…”
Section: Tensions Between the Historical Consensus And Clinical Practicementioning
confidence: 99%